Loading...
OTCM
BVNRY
Market cap2.07bUSD
Jun 23, Last price  
8.97USD
1D
0.56%
1Q
-7.50%
Jan 2017
-22.34%
Name

Bavarian Nordic A/S

Chart & Performance

D1W1MN
OTCM:BVNRY chart
P/E
3.30
P/S
0.74
EPS
17.83
Div Yield, %
—
Shrs. gr., 5y
7.62%
Rev. gr., 5y
27.21%
Revenues
6.17b
+7.96%
175,292,000332,103,000208,805,00074,783,000314,072,000523,601,0001,016,636,0001,212,501,0001,216,815,0001,020,561,0001,006,742,0001,370,151,000500,617,000662,488,0001,852,383,0001,897,875,0003,150,793,0007,062,340,0005,716,206,0006,171,025,000
Net income
1.38b
+39.21%
-160,937,000-63,504,000-216,242,000-395,988,000-576,969,000-324,339,000-240,001,000-46,729,00025,940,00059,426,00030,600,000181,343,000-361,927,000-346,777,000277,521,000-464,775,000-347,382,0001,475,189,000987,977,0001,375,378,000
CFO
2.72b
+39.60%
-194,493,000163,165,00022,411,000-484,139,000-239,862,000-375,236,00020,100,000147,084,000338,749,000105,323,000267,601,000216,065,000-288,529,000-275,910,000571,911,000-358,500,000220,053,0001,119,206,0001,949,832,0002,721,903,000
Dividend
Mar 27, 20200.59345 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.
URL
https://www.bavarian-nordic.com/
IPO date
Nov 02, 1998
Employees
1,354
Domiciled in
DK
Incorporated in
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT